Alexander van Akkooi

28PUBLICATIONS
107CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Dec 18, 2025
Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma.

Lisanne P Zijlker, Zahra Verwer, Bart A van der Wiel

|Oct 14, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Elan Novis, Mervi Rautalin, Rodabe N Amaria

|Oct 01, 2025
Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.

Judith M Versluis, Huma Shehwana, Robert Elens

|Sep 12, 2025
Cutaneous Melanoma Management-An Update and Narrative Review for the General Surgeon.

Matthew Binks, Alexander C J van Akkooi, Alexander M Menzies

|Aug 29, 2025
Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?

Alexander van Akkooi, Charlotte Ariyan, Marc Moncrieff

Pageof 5

Frequent Collaborators

7 joint publications

Michel W Wouters

6 joint publications

Georgina V Long

4 joint publications

Judith M Versluis

4 joint publications

Ellen Kapiteijn